Resultados de la búsqueda 21-30 of 1732 for Maximum

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    Maximum: 202 implanted subjects with up to 65 additional subjects implanted in Continued Access (Primary Study arm). A Study to Evaluate a Virtual Assistant ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    Maximum: 202 implanted subjects with up to 65 additional subjects implanted in Continued Access (Primary Study arm). The Use of Topical Tranexamic Acid in ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objectives of this study are to determine the maximum tolerated dose/recommended phase 2 dose (MTD/RP2D) of selumetinib + vinblastine for ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    Maximum: 202 implanted subjects with up to 65 additional subjects implanted in Continued Access (Primary Study arm). The Use of Topical Tranexamic Acid in ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    Maximum: 202 implanted subjects with up to 65 additional subjects implanted in Continued Access (Primary Study arm). A Study to Evaluate a Virtual Assistant ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to assess the safety and tolerability, identify dose-limiting toxicities (DLT) and determine the maximum tolerated dose (MTD) ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    Maximum: 202 implanted subjects with up to 65 additional subjects implanted in Continued Access (Primary Study arm). A Study to Assess Cisplatin and ...

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    Maximum: 202 implanted subjects with up to 65 additional subjects implanted in Continued Access (Primary Study arm). A Study to Assess Cisplatin and ...

  10. Cirugía - Ensayos clínicos - Mayo Clinic

    Maximum: 202 implanted subjects with up to 65 additional subjects implanted in Continued Access (Primary Study arm). The Use of Topical Tranexamic Acid in ...